GINA NULL: Open Payments
NPI 1851614648 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 118 payments from 27 companies in 2025. Trend: 2023 $1,679 · 2024 $1,956 · 2025 $2,510
Food & beverage: $2,270Education: $240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $456 |
| Daiichi Sankyo Inc. | 11 | $330 |
| Incyte Corporation | 5 | $326 |
| AstraZeneca Pharmaceuticals LP | 13 | $235 |
| Novartis Pharmaceuticals Corporation | 9 | $171 |
| Janssen Biotech, Inc. | 4 | $108 |
| Eisai Inc. | 5 | $105 |
| PFIZER INC. | 5 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Merck Sharp & Dohme LLC | 5 | $82 |
Products named: Enhertu, EPKINLY, IMFINZI, Zynyz, KISQALI, DATROWAY, IMBRUVICA, Lenvima.
Industry payments across AR — which companies pay providers there.
